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Linear kernel approacha b s t r a c t
Identifying unknown drug interactions is of great beneﬁt in the early detection of adverse drug reactions.
Despite existence of several resources for drug–drug interaction (DDI) information, the wealth of such
information is buried in a body of unstructured medical text which is growing exponentially. This calls
for developing text mining techniques for identifying DDIs. The state-of-the-art DDI extraction methods
use Support Vector Machines (SVMs) with non-linear composite kernels to explore diverse contexts in
literature. While computationally less expensive, linear kernel-based systems have not achieved a
comparable performance in DDI extraction tasks. In this work, we propose an efﬁcient and scalable sys-
tem using a linear kernel to identify DDI information. The proposed approach consists of two steps:
identifying DDIs and assigning one of four different DDI types to the predicted drug pairs. We demon-
strate that when equipped with a rich set of lexical and syntactic features, a linear SVM classiﬁer is able
to achieve a competitive performance in detecting DDIs. In addition, the one-against-one strategy proves
vital for addressing an imbalance issue in DDI type classiﬁcation. Applied to the DDIExtraction 2013 cor-
pus, our system achieves an F1 score of 0.670, as compared to 0.651 and 0.609 reported by the top two
participating teams in the DDIExtraction 2013 challenge, both based on non-linear kernel methods.
Published by Elsevier Inc. This is an open access article under the CC BY-NC-ND license (http://creative-
commons.org/licenses/by-nc-nd/4.0/).1. Introduction
New drugs are generally studied on relatively small and
homogeneous patient populations. As a result, pharmaceuticals
often have side effects that remain unnoticed until they are already
available to the public. This is especially true of side effects that
emerge when two drugs are co-administered. A change in the
effect of one drug in the presence of another drug is known as a
drug–drug interaction (DDI) [1]. It is characterized as an increase
or decrease in the action of either substance, or it may be an
adverse effect that is not normally associated with either drug.
Understanding these drug–drug interactions and their down-
stream effects is of signiﬁcant importance, leading to reduced
number of drug-safety incidents and reduced healthcare costs.
To address the DDI problem, a number of drug databases such
as DrugBank [2] and Stockley’s Drug Interactions [1] have been cre-
ated. Yet, they cover only a fraction of knowledge available. A large
amount of up-to-date information is still hidden in the text of jour-
nal articles, technical reports and adverse event reporting systems,and this body of unstructured published literature is growing
rapidly. MEDLINE, for example, has doubled in size within the last
decade and currently contains about 23 million documents. This
creates an urgent need for text mining techniques to extract DDI
information.
Using text mining techniques for DDI extraction has received
less attention compared to other biomedical relation extraction
tasks (e.g., protein–protein interactions), possibly due to the lack
of gold standard sets [3–6]. The DDIExtraction challenges are the
ﬁrst community-wide competition addressing the DDI extraction
problem [7,8] and a series of studies have been reported at the
2011 and 2013 challenge workshops [9–11].
Top performing systems in the DDIExtraction challenges use
Support Vector Machines (SVMs) with non-linear kernels [12,13].
To handle structural representations of input instances, such as
dependency graphs, non-linear kernels directly calculate similari-
ties between two graphs by comparing embedded subgraphs [14].
While non-linear kernels are theoretically capable of implicitly
searching a high dimensional feature space of subgraphs, existing
methods generally exploit only a partial feature space because of
the exponential number of subgraphs [15]. In addition, non-linear
kernels are frequently combined into composite kernels [12,11].
Composite kernels, however, incur more computational cost
because the complexity of the underlying kernels accumulates
Fig. 1. Two-phase DDI extraction framework. DDI detection (r) decides whether a
drug pair interacts. DDI type classiﬁcation (s) assigns DDI types to interacting
pairs.
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individual kernels.
Despite the popularity of non-linear kernel methods, linear ker-
nels are a good alternative for relation extraction tasks [16–18].
Linear kernels with word-level features alone provide a strong
baseline performance [11,12]. Moreover, they can explicitly
include nodes, edges and path structures of the dependency graphs
[17]. Also, the straightforward representation of linear kernels
enables the intuitive interpretation of obtained results. Most
importantly, when training large-scale datasets, it has been
demonstrated that often linear kernels are the only practical choice
[19,20]. However, the performance of linear kernel systems in DDI
extraction tasks has a noticeable gap from that of the top systems
using non-linear kernels [7,8,21].
We conjecture that linear kernel-based systems may beneﬁt
from a rich set of lexical and syntactic features. With the goal to
build a simple and scalable system, we develop a DDI extraction
system based on a single linear SVM classiﬁer. We deﬁne ﬁve types
of features to capture the complexity of data: word features with
position information, pairs of non-adjacent words, dependency
relations, parse tree structures and tags for differentiating DDI
pairs within the same noun phrase. Unlike other state-of-the-art
systems [13,21] which incorporate external, domain-speciﬁc
resources, our features originate exclusively from training data.
We evaluate our system on the DDIExtraction 2013 corpus [22].
Consistent with other studies [11–13], we adopt a two-phase
approach, where DDI pairs are identiﬁed ﬁrst, and then classiﬁed
into speciﬁc DDI types. The proposed method achieves an overall
F-score of 67% which outperforms the best performing system by
1.9%. We believe that the strength of our method comes from using
a diverse set of features. In addition, the one-against-one strategy
[23] used in the DDI type classiﬁcation contributes to the higher
performance. As the ﬁrst linear kernel method that achieves the
state-of-the-art performance on both DDI detection and classiﬁca-
tion tasks, we consider it a strong alternative to the nonlinear,
composite kernel-based approaches. The inherent simplicity of
the method adds transparency to the overall system, which could
be especially beneﬁcial if the system is used as a part of a more
complicated schema. The source code for generating the features
proposed in this article is available at http://www.ncbi.nlm.nih.
gov/IRET/DDI.2. Methods
Fig. 1 illustrates the overall architecture of our DDI extraction
system. A binary classiﬁer is trained ﬁrst to extract interacting drug
pairs from all candidate interactions. A DDI type classiﬁer is then
built to classify the interacting pairs into predeﬁned relation cate-
gories. Our approach focuses on interactions expressed within the
boundaries of a single sentence, and also assumes that drug enti-
ties involved in the target interactions have been annotated.
In this section, we ﬁrst elaborate the ﬁve types of features used,
including two novel features proposed for the DDI problem: word
pair and noun phrase-constrained coordination (NPC) features.
Then, we brieﬂy introduce the preprocessing steps completed on
both training and test data. Next, we describe our linear SVM clas-
siﬁer with a modiﬁed Huber loss function [24]. In the end, we com-
pare our method with existing DDI extraction systems.2.1. Features
2.1.1. Word features
Word-level features such as individual words in a sentence and
sequences of words have been demonstrated to provide a strong
performance baseline in extracting relational knowledge[11,17,25]. Hence, in our system, we use n-gram features of size
up to 3, i.e., unigrams, bigrams and trigrams. Including n-grams
of larger size does not always lead to a performance increase due
to the data sparseness problem [25]. Similar to the works of He
et al. [11] and Giuliano et al. [26], the position information is
appended to each word feature according to positions of words
in a sentence relative to an investigated drug pair: before (BF),
between (BE) and after (AF). For instance, ‘‘Interaction_BF of_BF
ketamine and_BE halothane in_AF rats_AF’’ where ‘‘ketamine’’
and ‘‘halothane’’ are two drug names.
2.1.2. Word pair features
While word features may capture repetitive expression patterns
in neighboring words, they are not able to discover patterns involv-
ing distant words in a sentence. A simple solution to capture dis-
tant word patterns is to extract all possible word combinations
from a training set. However, this approach increases the number
of features considerably, and it also may degrade classiﬁcation per-
formance. To address this issue, we here propose a novel technique
for selecting signiﬁcant word pairs.
First, unigram word features are paired and only those pairs
with a minimum frequency k are selected. Second, for selected
word pairs, p-values are calculated using the hypergeometric
distribution [27]. The p-value reﬂects how strongly a feature is
represented in the positive set as compared to the negative set. It
relates to the null hypothesis that the co-occurrence of two words
is randomly distributed between positive and negative sets. If the
co-occurrence is randomly distributed, the word pair will have a
high p-value. If the p-value is low, this indicates a 1 p probability
that the co-occurrence is not random and is likely indicative for
positive DDIs.
To obtain the most useful word pairs, we need the least restric-
tive frequency and the most restrictive p-value. In this work, we set
k ¼ 200 and p-value = 0.01 based on F1 scores via 10-fold docu-
ment-level cross validation on the training set. This signiﬁcant p-
value helps select 588 word pairs from a total of 449,826 pairs with
k above 200. This feature set contains certain informative word
pairs such as ‘‘drug1    drug2    increase    level’’ and
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signal indicating DDIs.
2.1.3. Dependency graph features
Dependency graphs use nodes to represent words in a sentence
and edges to describe governor-dependent relations between the
words. Thus, they can capture long-range dependencies among
sentential constituents by considerably narrowing the linear order
distance between target entities [19]. Since the syntactic depen-
dencies closely approximate the underlying semantic relation-
ships, they have been effectively used by biomedical knowledge
extraction systems [28,16,29–31].
While some approaches use an all-inclusive approach to explore
paths of all possible lengths between any two nodes in a depen-
dency graph [32,15], the shortest path between two nodes is par-
ticularly likely to carry the most valuable information about their
mutual relationship [33–36]. Given the dependency graph of each
sentence, therefore, the shortest dependency path connecting the
target drugs in the undirected version of the graph is selected. If
there exist multiple shortest paths, we randomly choose one. The
extracted path is then transformed into an ordered sequence of
individual dependency relations, in which original relation labels
and edge orientations are appropriately preserved. For instance, a
dependency path ‘‘ketamine  nsubj interacts !prep with halothane’’ is
encoded as ‘‘nsubj(interacts,ketamine); prep_with(inter-
acts,halothane)’’. We further split a dependency path into n-grams
of up to size 3. Compared to the vertex-walks based q-grams pro-
posed by Kuboyama et al. [37], our dependency features are equiva-
lent to q-bigrams in their work.
2.1.4. Parse tree features
We have observed in the training data of the DDIExtraction
2013 challenge [8] that the textual descriptions of more than
25% of the total 4023 interacting drug–drug pairs involve different
subordinate clauses of a sentence such as ‘‘If additional adrenergic
drugs are to be administered by any route, they should be used with
caution because the pharmacologically predictable sympathetic effects
of BROVANA may be potentiated.’’, or appear in the main sentence
and its subordinate clause for instance ‘‘When carbamazepine is
withdrawn from the combination therapy, aripiprazole dose should
then be reduced.’’ Capturing these grammatical patterns is thus
important to the successful extraction of these interactions.
Compared to constituent parse trees which inherently retain phra-
sal and clausal structures, dependency graphs do not explicitly pre-
serve this rich syntactic information.
It has been shown that systems exclusively relying on parse
trees obtain inferior results to using dependency graphs in infor-
mation extraction tasks [31,16]. However, combining information
from both representations improves the overall performance
[38,11]. To supplement our dependency features, we extracted
the shortest path connecting the two investigated drugs in the
parse tree. The resulting path is a sequence of grammatical tags
such as ‘‘NP S VP VP SBAR S VP PP NP’’, representing a concise syn-
tactic traverse from one drug to the other. To capture frequent syn-
tactic patterns, n-grams over individual tags of size 3 are used as
our parse tree features. Unlike word features and dependency
graph features, unigrams and bigrams are not used for parse tree
features because these patterns are too short to represent syntactic
structures.
2.1.5. Noun phrase-constrained coordination features
Linguistically, relationships are rarely discussed among entities
in syntactic constituents where 3 ormore target entities appear in a
coordination. For instance, in the sentence ‘‘Clidinium may decrease
the effect of phenothiazines, levodopa, and ketoconazole.’’, thecoordination structure ‘‘phenothiazines, levodopa, and ketocona-
zole’’ is used to enumerate a list of drugs that potentially interact
with ‘‘Clidinium’, with no indication of interactions among the
drugs inside the coordination.
In this work, we use base noun phrases to constrain the scope of
the coordinated drug mentions, and propose a novel, noun phrase-
constrained coordination feature to indicate if the target drugs are
coordinated in a noun phrase. Suppose the total number of drug
mentions in a base noun phrase NPb is n, the new feature f c for each
candidate DDI pair (d1; d2) is deﬁned as follows:
f cðd1;d2Þ ¼




Because of the cascaded structure, candidate noun phrases are
recursively extracted from the constituent parse trees. A base noun
phrase NPb is deﬁned to be the longest noun phrase that does not
contain any prepositional phrases (PP), verb phrases (VP), sub-
ordinate clauses (SBAR) or sentences (S). We observed only 16
interacting drug–drug pairs (0.2%) among the total 8045 pairs
satisfying f c = 1 in the DDIExtraction 2013 training data.2.2. Preprocessing
Several standard preprocessing steps are ﬁrst completed on
both training and test data. These include sentence segmentation
and tokenization, Part-of-Speech (POS) tagging and syntactic pars-
ing that produces constituent parse trees and dependency graphs
for sentences [39,40]. To ensure generalization of the features, drug
mentions are anonymized using ‘‘DRUG’’ for target drugs and
‘‘DRUG_OTHER’’ for other drugs. Numbers are replaced by a generic
tag ‘‘NUM’’, and other tokens normalized into their corresponding
lemmas by the BioLemmatizer [41].
The same drug mentions can appear multiple times in a sen-
tence. Considering that drugs are unlikely to interact with them-
selves, candidate pairs with both drugs referring to the same
name are removed [42,12]. This helps reduce candidate drug pairs.
In addition, we notice that drug names are sometimes separated by
a colon from the detailed description on their interactions with
other drugs. For instance, ‘‘Morphine: Combination hormonal con-
traceptives may increase the clearance of morphine.’’ In such cases,
as the description itself is an independent sentence, pairing
‘‘Morphine’’ on the left of the colon with drug mentions in the
description may interfere with the narrative ﬂow of the descrip-
tion. Thus, we remove the drug mentions on the left of the colon
from further consideration.
Fig. 2 shows the preprocessing step and the feature vector
obtained for an example sentence.2.3. SVM classiﬁer
For DDI detection and classiﬁcation, we use an SVM classiﬁer
with the modiﬁed Huber loss function [24]. We have observed that
the modiﬁed Huber loss function has consistently achieved better
performance than the hinge loss function used in traditional
SVMs for biomedical classiﬁcation problems [43,25,44]. Let T
denote the size of the training set. Let the binary feature vector
of the ith pair in the training set be denoted by Xi. Let yi ¼ 1 if
the pair is annotated as positive and yi ¼ 1 otherwise. Let w
denote a vector of feature weights, of the same length as Xi. Let h
denote a threshold parameter, and let k denote a regularization







hðyiðhþw  XiÞÞ; ð2Þ
Fig. 2. An example of preprocessing and feature extraction. The underlined drug pair, clidinium and phenothiazines, is the candidate DDI. ‘NPC’ means noun phrase-
constrained coordination and ‘BE’ denotes between candidate drugs.
2 What the body does to the drug; absorption, distribution, metabolism,
elimination.
3 What the drug does to the body.
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follows:
hðzÞ ¼
4z; if z 6 1;
ð1 zÞ2; if  1 < z < 1;
0; if 1 6 z:
8><
>: ð3Þ
The values of the parameters, w and h minimizing C are deter-
mined using a gradient descent algorithm. The regularization
parameter k is computed from the training set as follows:
k ¼ k0hjxji2; ð4Þ
where hjxji is the average Euclidean norm of the feature vectors in
the training set. The parameter k0 is set to 0.00001 for the DDI task.
2.4. Comparison with existing DDI extraction systems
Our linear SVM classiﬁer relies on a set of general features to
achieve the state-of-the-art performance. Word-level features,
dependency graphs and parse trees are commonly used by relation
extraction systems [31,17,12,11]. Compared to the implicit use in
non-linear kernel systems [11,12], features extracted from depen-
dency graphs and parse trees are represented as linear n-grams in
our system. As the only linear kernel system of the top 3
DDIExtraction 2013 teams, UTurku [21] makes intensive use of
dependency graph features, but does not take advantage of the rich
syntactic information in parse trees. In our system, both are used to
complement each other for multiple aspects of structural analysis
of sentences.
The noun phrase-constrained coordination and word pair fea-
tures are novel in our DDI extraction approach. He et al. [11] aimed
for general conjunction structures around investigated drugs by
encoding relative distances into features. However, our coordina-
tion feature is able to explicitly capture the coordination structure
of enumerated drugs, and semantically constrain the scope of the
structure by noun phrases. Also, even though Bobic´ et al. [45] com-
bined non-adjacent tokens across sections (‘‘BF’’, ‘‘BE’’ and ‘‘AF’’),
they used all the combinations without any feature selection. We
ﬁnd that the feature selection using p-values is effective for reduc-
ing the data complexity and for improving the DDI extraction
performance.
In addition, Björne et al. [21] took advantage of domain knowl-
edge derived from DrugBank [2] and MetaMap [46]. Besidesdomain-speciﬁc resources, He et al. [11] additionally asked
domain experts to manually compile keyword and semantic type
features. Considering that our features originate exclusively from
training data and their extraction is domain independent, our fea-
ture types may be more generalizable to other relation extraction
tasks.
3. Results and discussion
3.1. Dataset
We train and evaluate the proposed approach on the DDI corpus
from the DDIExtraction 2013 challenge [8]. The DDI corpus
includes 905 manually annotated documents from the DrugBank
database and MEDLINE abstracts, which are split into 714 and
191 documents for training and test sets, respectively. The DDI
set provides examples by sentences and, for each sentence, all drug
mentions and DDI pairs are annotated. There are four different
types of DDI relationships in the set [22]; mechanism, effect, advice
and int. Mechanism is used for DDIs that are described by their
pharmacokinetic (PK) mechanism.2 Effect is for DDIs describing an
effect or a pharmacodynamic (PD) mechanism.3 Advice is used when
a recommendation or advice related to a DDI is given. Int is used
when a DDI appears in a sentence without providing any additional
information.
Non-interacting drug pairs are not explicitly provided in the
DDI corpus. Hence, all drug pairs that do not overlap with positives
are considered as negatives. Table 1 shows the number of positive
and negative pairs before and after preprocessing. Removing pairs
with the same drug mentions and the colon case described in
Preprocessing ﬁlters out 29 positive and 3972 negative pairs. The
removed positive pairs constitute 0.58% of the positive set. We ﬁnd
the fraction to be negligible compared to the advantage of not
showing nearly 14% negative pairs to SVM classiﬁers. In a basic set-
ting where only word features are used, this step improves F1 by
4% using 10-fold document-level cross validation on the training
set.
Table 1
Number of positive and negative pairs in the dataset. 29 positive and 3972 negative
pairs were removed through preprocessing.
Original set Preprocessed set
Positive Negative Positive Negative
Training 4023 23,756 3996 20,368
Test 979 4734 977 4150
Total 5002 28,490 4973 24,518
Table 3
Performance comparison between the proposed method and top-ranking approaches
on the DDIExtraction 2013 test data. The performance is measured based on F1 scores.
‘CLA’ indicates detection and classiﬁcation performance for all classes. ‘DEC’ indicates
detection performance. ‘MEC’, ‘EFF’, ‘ADV’ and ‘INT’ are for mechanism, effect, advice
and int types respectively. The highest scores are highlighted in bold.
Method CLA DEC MEC EFF ADV INT
Our method 0.670 0.775 0.693 0.662 0.725 0.483
FBK-irst 0.651 0.800 0.679 0.628 0.692 0.547
WBI 0.609 0.759 0.618 0.610 0.632 0.510
UTurku 0.594 0.696 0.582 0.600 0.630 0.507
Table 4
Performance comparison between DrugBank and MEDLINE test sets in DDIExtraction
2013. The performance is measured based on F1 scores. ‘CLA’ indicates detection and
classiﬁcation performance for all classes. ‘DEC’ indicates detection performance.
‘MEC’, ‘EFF’, ‘ADV’ and ‘INT’ are formechanism, effect, advice and int types respectively.
Dataset CLA DEC MEC EFF ADV INT
DrugBank 0.698 0.804 0.714 0.706 0.736 0.497
MEDLINE 0.382 0.471 0.455 0.352 0.429 0.250
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and test sets for each DDI type. Mechanism and effect are dominant
classes, while advice and int contain many fewer instances com-
prising about 25% of the positive set. This unbalanced size in the
training data may be problematic, in particular, for a machine
learning solution because it may lead to poor classiﬁcation perfor-
mance [47]. To address the issue, we apply the one-against-one
approach for the DDI type classiﬁcation task. Compared to the
one-against-all strategy which takes negative examples from all
non-positive classes, the one-against-one strategy uses only one
negative class for each classiﬁer; it alleviates the imbalance.
3.2. Performance comparison
Eight teams participated in the DDIExtraction 2013 challenge,
and the ofﬁcial performance ranged from 21.4% to 65.1% F1 [8].
Table 3 compares our method with the top three ranking teams
in the DDIExtraction task based on F1 scores. Our approach
achieves 67% F1 for detection and classiﬁcation performance
(‘CLA’), whereas FBK-irst, WBI and UTurku produced 65.1%, 60.9%
and 59.4% F1, respectively. For DDI detection performance (DEC),
i.e. before applying the one-against-one strategy, the proposed
approach performs second best by achieving 77.5% F1.
FBK-irst [12] uses a hybrid kernel for combining linear features,
shallow linguistic and path-enclosed tree kernels. WBI [13] utilizes
an ensemble approach to combine outputs from other DDI predic-
tion tools. UTurku [21] uses a linear kernel with domain knowl-
edge from external resources as well as word and dependency
graph features. For DDI type classiﬁcation, FBK-irst uses binary
SVMs with a one-against-all strategy. WBI and UTurku use a
multi-class SVM, which does not require choosing either one-
against-one or one-against-all. Our method, on the other hand, uses
a simple binary SVM classiﬁer with linear kernel for identifying
DDIs and the one-against-one strategy for assigning DDI types.
We choose the one-against-one strategy to reduce the negative
effect of unbalanced classes. In Table 3, our approach performs best
for mechanism, effect and advice types. In contrast, the same
approach does not perform well for int. This is different from the
10-fold document-level cross validation results for the training
set (Refer to Section 3.4). By deﬁnition, int contains DDIs which
cannot be assigned to other three types. Thus, either the general
description of int or insufﬁcient evidence from the small number
of training (188 examples) and testing (96 examples) sets may play
a role.Table 2
Positive drug pairs used for training and testing. The preprocessed set is compared
with the original set.
Class Original set Preprocessed set
Training Test Training Test
Mechanism 1321 302 1309 301
Effect 1688 360 1675 359
Advice 826 221 824 221
Int 188 96 188 96
Total 4023 979 3996 977Furthermore, Table 4 shows the separate performance of our
system on DrugBank and MEDLINE test documents. While the
DDI detection and classiﬁcation (‘CLA’) performance on the
DrugBank set shows 69.8% F1, the performance on the MEDLINE
set is substantially lower (38.2% F1). This difference is consistent
with the results from the DDIExtraction 2013 challenge [8]. It
may be due to the small number of training examples provided
for MEDLINE. The 232 DDI pairs in the MEDLINE training set con-
stitute only 6% of the overall training data. In addition, the
DrugBank and MEDLINE documents may have different character-
istics [12].
In the following subsections, we discuss the contribution of
each feature type and the effect of the one-against-one strategy
compared to the one-against-all strategy.
3.3. Feature analysis
Table 5 presents changes of DDI detection performance by add-
ing each feature type to the baseline (word features). For the
results, 10-fold document-level cross validation was performed
ten times and the scores were averaged. Relative positions
attached to word features improve the F1 performance by 24.1%.
This signiﬁcant improvement is understandable because relative
position is a good indicator whether an individual word is used
in describing DDIs.
Using word features with positions as a baseline, word pairs,
dependency relations, parse trees and NPC are added and evalu-
ated individually. From the table, word pairs and parse trees con-
tribute the most by increasing F1 by 1.9% and 1.4%, respectively.
Dependency relations and NPC have less impact on the perfor-
mance, however, dependency relations help get higher precision
and NPC helps the recall. While word features cover neighboring
words, syntactic structure and word pair features seem to help
with the overall picture of DDI sentences. It is understandable,
yet remarkable that using words with relative positions alone
achieves such high performance for identifying DDIs. Integrating
position information into word features is important because one
sentence often involves multiple drug mentions and the position
information helps differentiate the context of interacting pairs
from that of non-interacting ones. It would be interesting to see
how the same strategy would work on other entity–entity relation-
ship extraction tasks.
An advantage of using the linear kernel approach is that
obtained results have an intuitive interpretation. Although
Table 5
Performance changes by varying feature types in DDI detection. The baseline
performance was measured by using word features with position (‘pos’) information.
‘Change’ shows the F1 score difference between the baseline and the performance in
each row. 10-fold document-level cross-validation was performed ten times for the
training set and scores were averaged.
Features Precision Recall F1 Change
Baseline (w/o pos) 0.544 0.427 0.478 24.1%
Baseline 0.774 0.670 0.719 –
+ Word pairs 0.780 0.700 0.738 +1.9%
+ Dependency 0.791 0.669 0.725 +0.6%
+ Parse trees 0.783 0.688 0.733 +1.4%
+ NPC 0.771 0.681 0.723 +0.4%
All features 0.798 0.711 0.752 +3.3%
Table 6
Performance comparison on the one-against-all strategy. 10-fold document-level
cross-validation was performed ten times for the training set and scores were
averaged.
Class Precision Recall F1
Mechanism 0.911 0.774 0.837
Effect 0.885 0.839 0.861
Advice 0.894 0.830 0.861
Int 0.725 0.495 0.587
Table 7
Performance comparison on the one-against-one strategy. 10-fold document-level
cross-validation was performed ten times for the training set and scores were
averaged.
Class Precision Recall F1
Mechanism 0.941 0.964 0.952
Effect 0.943 0.979 0.960
Advice 0.921 0.960 0.940
Int 0.912 0.953 0.932
Table 8
Performance comparison (F1 scores) of the one-against-all and one-against-one
28 S. Kim et al. / Journal of Biomedical Informatics 55 (2015) 23–30Table 5 provides some information, it still lacks in explaining what
features contribute to identify a particular DDI in a sentence. Fig. 3
shows a simple visual aid, where signiﬁcant words are highlighted
based on the weights of word and word pair features from the SVM
classiﬁer. The features listed are the ones that classify the example
as positive. The words with higher weights are emphasized by
thicker lines and darker gray. From the highlighted words, one
can understand that ‘‘DRUG with DRUG’’ and ‘‘not recommended’’





Int 0.440 0.4833.4. DDI type detection
Our approach to DDI extraction has two steps. First, drug pairs
are classiﬁed whether they interact or not. Second, one of four DDI
types (mechanism, effect, advice and int) is assigned to interacting
pairs.
Two popular ways to address multi-class classiﬁcation using
binary classiﬁers are the one-against-one and one-against-all strate-
gies [23]. The one-against-all method builds a classiﬁer for each
class vs. all other classes. The one-against-one strategy, however,
builds a binary classiﬁer for each pair of classes, and the output
of the classiﬁers is aggregated using majority voting. DDI type clas-
siﬁcation requires 4 and 12 classiﬁers for one-against-all and one-
against-one, respectively.
A critical issue for the DDI type classiﬁcation is that the number
of training examples differs signiﬁcantly among the four classes
(Table 2). For the one-against-all strategy, this imbalance may lead
to poor performance on the small classes. Therefore, we use the
one-against-one strategy for the DDI classiﬁcation task. Tables 6
and 7 present the performance difference between one-against-all
and one-against-one. The performance is better and more balancedFig. 3. A solution for presenting drug pairs with signiﬁcant word and word pair features.
all the weights they receive in the feature list. ‘BF’, ‘BE’ and ‘AF’ mean before, between awith the one-against-one strategy. Table 8 shows F1 scores for one-
against-all and one-against-one on the test set. Although there is a
slight performance decrease on effect, F1 scores increase on other
DDI types.
3.5. Annotation inconsistency
The proposed method is completely data-driven. Even though
SVM classiﬁers are robust to noisy training examples to some
degree, our approach is sensitive to the quality of the training set.
During algorithm development, we found that the DDI corpus
contained irregularly formatted sentences. In one case, section
titles are concatenated with the next sentence as shown in Fig. 4.
A more severe problem can occur when tables are converted to
text. Sentences derived from tables can cause false positive andHighly weighted words are highlighted in the sentence and emphasized according to
nd after, respectively. DRUG indicates a target drug.
Corticosteroids: Concomitant administration of aspirin and corticosteriods 
may decrease salicylate plasma levels. 
Theophylline:
As with some other quinolones, concurrent administration of ciprofloxacin
with theophylline may lead to elevated serum concentrations of 
theophylline and prolongation of its elimination half-life. 
Fig. 4. Example sentences which start with ‘‘[drug name]:’’. ‘‘[drug name]:’’ is a section title which is concatenated with the next sentence in the DDIExtraction set.
Corticosteroids: A relationship of functional antagonism exists between 
vitamin D analogues, which promote calcium absorption, and 
corticosteroids, which inhibit calcium absorption.
Corticosteroids: Concomitant administration of aspirin and corticosteroids
may decrease salicylate plasma levels.
Fig. 5. Example sentences, where some drug names are not annotated. ‘‘calcium’’ in the ﬁrst sentence and the second ‘‘corticosteroids’’ in the second sentence are not
annotated as drug names.
S. Kim et al. / Journal of Biomedical Informatics 55 (2015) 23–30 29false negative drug pairs. Positive drug pairs from a table are not
useful because the proposed approach is designed for grammati-
cally well-formed text. In our experiments, we kept the table-
derived sentences because no rules could be found to remove
them. We presume that DrugBank sentences were automatically
extracted from HTML or XML data prior to annotation, or curators
annotated the dataset in a structured form and it was later ﬂat-
tened by an automatic extraction process.
Another problem in the dataset is that not all drug mentions are
annotated. In Fig. 5, ‘‘calcium’’ in the ﬁrst sentence and the second
‘‘corticosteroids’’ in the second sentence are not annotated as drug
names. It is obvious that ‘‘corticosteroids’’ in the second example is
overlooked by curators. However, it is difﬁcult to decide whether
‘‘calcium’’ is a drug name here. While ‘‘calcium’’ is often annotated
as a drug in the dataset, there are also exceptions where ‘‘calcium’’
is not considered a drug. We assume that it is either overlooked or
not considered a drug.
4. Conclusion
We present a two-step classiﬁcation algorithm for identifying
DDIs from biomedical literature. Unlike other state-of-the-art
approaches, the proposed method focuses on word and syntactic
features in a linear SVM. For assigning DDI types to drug pairs,
positive DDI pairs are ﬁrst identiﬁed by a single SVM classiﬁer,
and multiple SVM classiﬁers are used to decide DDI types through
the one-against-one strategy in the second step. The features used
in our approach are words with relative positions, pairs of non-
adjacent words, dependency relations, syntactic structures and
noun phrase-constrained coordination tags. Applied to the
DDIExtraction corpus, the proposed method showed competitive
performance to top-ranking teams in the DDIExtraction 2013 chal-
lenge by obtaining 67% F1.
The main contribution of the proposed method is the rich-
feature based approach using linear SVMs. Non-linear, composite
kernel approaches can directly use structural information. However,
they tend to be complex and may not be readily applicable to a
large-scale dataset. Our feature-based approach, on the other hand,
is more ﬂexible. Feature types can be easily evaluated, hence an
intuitive interpretation is readily available. The linear kernel
approach is also a practical alternative for large-scale problems.
Moreover, the one-against-one strategy used in the DDI type classi-
ﬁcation is found to be useful for achieving higher classiﬁcation
performance. It addresses some difﬁculties of solving multi-classclassiﬁcation with binary classiﬁers. As future work, we plan to
extend our system by integrating it with named entity recognition
tools. We also would like to evaluate the end-to-end DDI extraction
system for PubMed abstracts in a large-scale setting.Acknowledgments
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